Artemis Medicare Services Ltd

₹ 263 0.61%

17 Jun 2:15 p.m.

artemishospitals.com BSE: 542919 NSE: ARTEMISMED

About

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. ^[1]^[2]

Key Points

Business Profile^[1]
Promoted by Apollo Tyres Group, Artemis Medicare Services Ltd manages multi-specialty hospitals in Haryana under the brand Artemis Hospitals. The company provides a comprehensive range of advanced medical and surgical services across specialties such as cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, and critical care.

Website BSE NSE

Market Cap ₹ 4,162 Cr.
Current Price ₹ 263
High / Low ₹ 298 / 203
Stock P/E 39.3
Book Value ₹ 59.0
Dividend Yield 0.17 %
ROCE 14.6 %
ROE 12.0 %
Face Value ₹ 1.00

Add ratio to table

Edit ratios

Pros

Company has delivered good profit growth of 76.6% CAGR over last 5 years

Cons

Stock is trading at 4.41 times its book value
Company has a low return on equity of 12.2% over last 3 years.
Promoter holding has decreased over last 3 years: -10.5%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE 1000 BSE Hospitals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	195	210	225	219	225	223	241	232	240	255	275	272	279
	170	182	191	186	187	187	199	195	204	214	224	228	228
Operating Profit	26	28	34	33	38	36	42	37	36	41	51	45	52
OPM %	13%	13%	15%	15%	17%	16%	18%	16%	15%	16%	18%	16%	18%
	2	1	2	2	2	4	7	9	12	7	8	4	8
Interest	5	7	8	8	9	8	8	8	8	7	7	7	6
Depreciation	9	9	10	10	11	11	11	11	12	11	12	12	13
Profit before tax	14	13	19	16	20	22	31	27	29	30	39	30	40
Tax %	24%	26%	28%	29%	29%	24%	28%	23%	20%	29%	24%	25%	25%
	11	10	14	12	14	17	22	21	23	21	30	22	30
EPS in Rs	0.79	0.72	1.00	0.85	1.04	1.22	1.62	1.50	1.67	1.53	2.16	1.41	1.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	547	565	408	555	737	879	937	1,081
	481	503	373	487	643	746	785	893
Operating Profit	66	62	35	68	94	133	152	188
OPM %	12%	11%	9%	12%	13%	15%	16%	17%
	2	4	7	3	7	7	33	27
Interest	11	13	13	12	20	31	32	28
Depreciation	20	23	22	22	31	40	45	48
Profit before tax	37	31	8	37	51	68	108	139
Tax %	45%	36%	18%	16%	25%	28%	24%	25%
	20	19	6	31	38	49	82	104
EPS in Rs	0.97	1.49	0.49	2.40	2.88	3.62	6.00	6.55
Dividend Payout %	0%	0%	0%	0%	16%	12%	7%	7%

Compounded Sales Growth
10 Years:	%
5 Years:	22%
3 Years:	14%
TTM:	15%

Compounded Profit Growth
10 Years:	%
5 Years:	77%
3 Years:	41%
TTM:	28%

Stock Price CAGR
10 Years:	%
5 Years:	54%
3 Years:	35%
1 Year:	4%

Return on Equity
10 Years:	%
5 Years:	11%
3 Years:	12%
Last Year:	12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	13	13	13	13	14	14	16
Reserves	280	300	307	346	390	435	824	919
	114	113	147	201	286	320	290	262
	147	160	133	149	216	203	229	232
Total Liabilities	554	586	600	710	905	972	1,357	1,429
	381	393	383	489	605	719	745	805
CWIP	49	56	81	64	95	33	40	28
Investments	0	0	0	0	0	0	0	0
	124	137	136	157	205	219	572	596
Total Assets	554	586	600	710	905	972	1,357	1,429

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	40	56	27	60	127	109	146	132
	-50	-26	-37	-107	-158	-88	-385	-90
	14	-27	18	44	38	-29	267	-50
Net Cash Flow	5	2	8	-3	7	-8	27	-8
Free Cash Flow	-17	30	-4	-49	-18	37	55	32
CFO/OP	76%	98%	83%	63%	138%	94%	105%	79%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52	49	49	48	46	39	39	40
Inventory Days
Days Payable
Cash Conversion Cycle	52	49	49	48	46	39	39	40
Working Capital Days	-51	-36	-36	-26	-43	-27	-28	-17
ROCE %		10%	4%	10%	11%	14%	15%	15%

Insights

In beta

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

ARPOB
INR ・Standalone data

xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx
xx,xxx	x,xxx	x,xxx	xx,xxx	xx,xxx	xx,xxx
xxx	xxx	xxx	xxx	xxx	xxx
xxx	xxx	xxx		xxx	xxx
			xx	xx	xx

Please log in to see hidden values.

Average Length of Stay (ALOS)
Days ・Standalone data

Occupancy Rate
% ・Standalone data

Patient Volume (In-Patient)
Number ・Standalone data

Surgeries Performed
Number ・Standalone data

Total Bed Capacity
Number ・Standalone data

Operational Beds
Number ・Standalone data

Revenue Share from International Patients
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	68.03%	68.03%	68.03%	68.03%	67.51%	67.17%	67.17%	67.17%	66.53%	66.53%	58.38%	58.39%
	0.07%	0.09%	0.11%	0.10%	0.16%	0.21%	0.65%	0.31%	0.24%	0.37%	12.47%	12.19%
	1.41%	1.51%	1.96%	2.61%	3.45%	3.60%	4.51%	5.04%	4.76%	4.27%	2.91%	2.89%
	7.18%	7.18%	7.18%	7.18%	7.12%	7.09%	7.09%	7.09%	7.02%	7.02%	6.16%	6.16%
	23.30%	23.18%	22.72%	22.08%	21.76%	21.93%	20.59%	20.39%	21.45%	21.81%	20.07%	20.37%
No. of Shareholders	19,082	20,529	22,375	19,993	19,795	26,054	27,004	28,397	31,614	33,559	31,602	32,044

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	69.82%	69.82%	69.82%	68.91%	68.03%	67.17%	58.39%
	0.00%	0.00%	0.00%	0.00%	0.10%	0.31%	12.19%
	1.22%	1.22%	1.10%	1.37%	2.61%	5.04%	2.89%
	7.37%	7.37%	7.37%	7.27%	7.18%	7.09%	6.16%
	21.59%	21.59%	21.71%	22.43%	22.08%	20.39%	20.37%
No. of Shareholders	5,590	5,273	12,098	18,100	19,993	28,397	32,044

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

May 2026
Transcript PPT
Feb 2026
Transcript PPT REC
Nov 2025
Transcript PPT
Aug 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
Feb 2025

Transcript

AI Summary
PPT
Nov 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Nov 2023

Transcript

AI Summary
PPT
Aug 2023

Transcript

AI Summary
PPT
May 2023

Transcript

AI Summary
PPT
Feb 2023

Transcript

AI Summary
PPT
Nov 2022

Transcript

AI Summary
PPT